New York, NY - Today, Congresswoman Carolyn B. Maloney (NY-12) convened a roundtable at LIM College with manufacturers, designers, and the Garment District Business Improvement District.
Two House committees on Monday requested a slew of documents from the pharmaceutical company Biogen as part of an investigation into the controversial approval of its Alzheimer's treatment.
A pair of congressional hearings on Capitol Hill in May served as a perfect setting for Democrats and Republicans to take shots at Wall Street’s most powerful bank CEOs.
I hope you’ll join me for Mobile Casework Hours this Sunday, July 11 at the Steinway Street Station or on Wednesday, July 14 in Koreatown (32nd Street between 5th and Broadway). My staff and I will be there to answer questions and provide help with federal agencies.
Queens Rep. Carolyn B. Maloney joined advocates in front of Wells Fargo on Madison on Friday to call on Congress to pass legislation to keep overdraft fee practices in check.
The Overdraft Protection Act of 2021, introduced by Maloney last week, would improve the transparency of overdraft programs for consumers.
Democratic Rep. Carolyn Maloney of Manhattan has long lobbied for paid family leave. Now with support from the Biden administration’s American Families Plan, she’s gotten a measure known as the Comprehensive Paid Leave for Federal Employees Act through the House Committee on Oversight and Reform, which she chairs.
BROOKLYN, NY – Congresswoman Carolyn B. Maloney (D-NY) this week visited the North Brooklyn Angels’ new facility on Kent Street.
NEW YORK, NY- Today, Congresswoman Carolyn B. Maloney (D-NY), senior member of the House Financial Services Committee, was joined by consumer protection advocates in calling on Congress to pass H.R. 4277, the Overdraft Protection Act of 2021. The group gathered in front of the Wells Fargo at 545 Madison.
House Democrats on Thursday released a report that found that the 14 leading drug companies paid out more in stock buybacks and dividends from 2016 to 2020 than they spent on research and development.